Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.740
+0.200 (5.65%)
At close: Mar 16, 2026, 4:00 PM EDT
3.750
+0.010 (0.27%)
After-hours: Mar 16, 2026, 5:46 PM EDT
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $451.03 million as of March 16, 2026. Its market cap has increased by 114.37% in one year.
Market Cap
451.03M
Enterprise Value
301.78M
1-Year Change
114.37%
Ranking
Category
Stock Price
$3.74
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.50M to $451.03M, an increase of 110.27%. That is a compound annual growth rate of 7.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 383.50M | 17.60% |
| Dec 31, 2025 | 326.10M | 84.13% |
| Dec 31, 2024 | 177.10M | 138.04% |
| Dec 29, 2023 | 74.40M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.98% |
| Dec 31, 2021 | 890.20M | 220.56% |
| Dec 31, 2020 | 277.70M | 255.12% |
| Dec 31, 2019 | 78.20M | -74.15% |
| Dec 31, 2018 | 302.50M | -60.22% |
| Dec 29, 2017 | 760.40M | 30.72% |
| Dec 30, 2016 | 581.70M | 7.13% |
| Dec 31, 2015 | 543.00M | 153.15% |
| Oct 7, 2015 | 214.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Invivyd | 471.93M |
| Altimmune | 470.85M |
| Maravai LifeSciences Holdings | 461.11M |
| Eupraxia Pharmaceuticals | 455.22M |
| Assembly Biosciences | 454.58M |
| REGENXBIO | 453.68M |
| Relmada Therapeutics | 453.20M |
| Century Therapeutics | 436.73M |